Based on gene expression analysis in CD34+ hematopoietic stem cells from Brazilian MDS patients, we identified that the BRCA1 gene was downregulated in patients with >5% blast cells and in patients who died [43]. Here, BRCA1 is linked to myelodysplastic syndrome.